# EDGAR Filing Document

**Accession Number:** 0001430306
**File Stem:** 0001999371-25-012337
**Filing Date:** 2025-8
**Character Count:** 2223
**Document Hash:** e2e5299d09246934251f35e4171f340c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001999371-25-012337.hdr.sgml**: 20251121

**ACCESSION NUMBER**: 0001999371-25-012337

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tonix Pharmaceuticals Holding Corp.
- **CENTRAL INDEX KEY:** 0001430306
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 261434750
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 26 MAIN STREET, SUITE 101
- **CITY:** CHATHAM
- **STATE:** NJ
- **ZIP:** 07928
- **BUSINESS PHONE:** 212-980-9155

**MAIL ADDRESS:**
- **STREET 1:** 26 MAIN STREET, SUITE 101
- **CITY:** CHATHAM
- **STATE:** NJ
- **ZIP:** 07928

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TAMANDARE EXPLORATIONS INC.
- **DATE OF NAME CHANGE:** 20080320

**Tonix Pharmaceuticals Holding Corp.**

**26 Main Street, Suite 101**

**Chatham, New Jersey 07928**

August 29, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Tonix Pharmaceuticals Holding Corp.** |
|  | **Registration Statement on Form S-3 (File No. 333-287965)** |
|  | **Filed on June 12, 2025** |

---

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Tonix Pharmaceuticals Holding Corp. hereby requests that the above-referenced Registration Statement (the "<u>Registration Statement</u>") be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on September 3, 2025, or as soon as practicable thereafter.

Please call Irina Ishak of Lowenstein Sandler LLP at (973) 422-6406 to confirm the effectiveness of the Registration Statement or with any questions.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **TONIX PHARMACEUTICALS HOLDINGS CORP.** | **TONIX PHARMACEUTICALS HOLDINGS CORP.** |
| By: | /s/ Bradley Saenger |
| Name: | Bradley Saenger |
| Title: | Chief Financial Officer |

---